Hipolin

Who are the top shareholders of the Hipolin?

The top shareholder of Hipolin is Kinnari Vaibhav Shah, owning 18.75%, with promoters holding a total of 39.76% pledged shares. Public shareholders include Arunaben Manherlal Vakil at 1.65%, while individual investors collectively hold 23.17%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Hipolin primarily consist of promoters, with Kinnari Vaibhav Shah holding the largest share at 18.75%. The promoters collectively have a pledged holding of 39.7627%. In terms of public shareholders, Arunaben Manherlal Vakil is the highest individual shareholder, owning 1.65%. Additionally, individual investors collectively hold 23.17% of the company. Notably, there are currently no mutual funds or foreign institutional investors (FIIs) holding shares in Hipolin.

What does Hipolin do?

Hipolin Ltd is a micro-cap company in the FMCG sector, incorporated in 1994, with recent quarterly results showing net sales of 4 Cr and a net loss of 2 Cr as of March 2025. The company has a market cap of Rs 28 Cr and key metrics include a debt-equity ratio of 0.22 and a return on equity of -40.05%.

Overview:<BR>Hipolin Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History:<BR>Hipolin was incorporated on 31 March 1994. The company has not reported any significant status changes since its incorporation. The latest quarterly results indicate net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 4 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -2 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 28 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.22 <BR>Return on Equity: -40.05% <BR>Price to Book: 3.48<BR><BR>Contact Details:<BR>Address: A/1/1 Nilkanth Indus Estate, Sanand - Viramgam Highway Virochannagar Gujarat : 382170 <BR>Tel: 91-2717-284202 <BR>Email: hipolin@hipolin.com <BR>Website: http://www.hipolin.com

Has Hipolin declared dividend?

Hipolin Ltd has declared a 10% dividend, amounting to 1.0000 per share, but the dividend yield is 0%. While recent short-term returns are negative, long-term returns have shown significant growth.

Hipolin Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: Sep-23-2010<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -48.32%, the dividend return was 0%, resulting in a total return of -48.32%.<BR><BR>For the 1-year period, the price return was -29.69%, the dividend return was 0%, leading to a total return of -29.69%.<BR><BR>Over the 2-year period, the price return was -2.0%, the dividend return was 0%, which resulted in a total return of -2.0%.<BR><BR>In the 3-year period, the price return was 139.02%, the dividend return was 0%, culminating in a total return of 139.02%.<BR><BR>For the 4-year period, the price return was 159.41%, the dividend return was 0%, resulting in a total return of 159.41%.<BR><BR>In the 5-year period, the price return was 375.47%, the dividend return was 0%, leading to a total return of 375.47%.<BR><BR>Overall, while Hipolin Ltd has declared a dividend, the dividend yield is 0%, indicating that the dividend does not contribute to the returns in recent periods. The total returns show significant fluctuations, with strong positive returns over longer periods despite negative returns in the short term.

Who are the peers of the Hipolin?

Hipolin's peers include Hind. Unilever, ITC, Nestle India, and Britannia Inds., among others. Hipolin has below-average management risk, growth, and capital structure, with the lowest 1-year return at -32.35% compared to its peers.

Peers: The peers of Hipolin are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Chothani Foods, Novateor Resear., Indong Tea Co, and BKV Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Below Average management risk is present at Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest. Growth is Average at Nestle India, while Below Average growth is noted for Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest. Excellent capital structure is seen at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, while Below Average capital structure is noted for Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest.<BR><BR>Return Snapshot: Chothani Foods has the highest 1-year return at 29.06%, while Hipolin has the lowest at -32.35%, indicating that Hipolin's performance is significantly worse than its peers. Additionally, the six-month return is negative for Hipolin, Hind. Unilever, ITC, Godrej Consumer, Chothani Foods, Indong Tea Co, and BKV Industries.

Is Hipolin overvalued or undervalued?

As of April 25, 2023, Hipolin is considered risky and overvalued due to its negative PE ratio of -8.55, poor returns on capital and equity, and significant underperformance compared to industry peers and the Sensex.

As of 25 April 2023, Hipolin's valuation grade has moved from does not qualify to risky, indicating a significant deterioration in its financial health. The company is currently overvalued, as evidenced by its negative PE ratio of -8.55 and an EV to EBITDA ratio of -8.97, which are starkly unfavorable compared to industry peers. Additionally, Hipolin's ROCE stands at -34.00% and ROE at -40.05%, reflecting substantial inefficiencies in generating returns.<BR><BR>In comparison to its peers, such as Hindustan Unilever with a PE ratio of 53.88 and Nestle India at 75.2, Hipolin's financial metrics are alarmingly poor. The EV to Sales ratio of 1.38 also suggests that investors are paying a premium for a company that is struggling to generate profits. Notably, Hipolin's stock has underperformed significantly against the Sensex, with a year-to-date return of -43.47% compared to the Sensex's 5.63%, reinforcing the perception of overvaluation.

What is the technical trend for Hipolin?

As of June 2, 2025, Hipolin's technical trend is mildly bearish, with mixed signals from various indicators, including bearish moving averages and Bollinger Bands, contrasted by some mildly bullish weekly indicators.

As of 2 June 2025, the technical trend for Hipolin has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across time frames. The Bollinger Bands are bearish on both weekly and monthly charts, and daily moving averages also reflect a bearish trend. The KST shows a mildly bullish weekly outlook but is mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance with a mildly bullish monthly view. The OBV is mildly bearish weekly but bullish monthly, adding to the mixed signals. Overall, the current technical stance is mildly bearish, driven primarily by bearish moving averages and Bollinger Bands, despite some mildly bullish indicators on the weekly time frame.

Who are in the management team of Hipolin?

As of March 2023, the management team of Hipolin includes Shaileshkumar Jayantilal Shah (Chairman/Executive Director), Daxesh B Shah, Samir Rohit Shah, Dimpal Sheth (Executive Directors), and several Independent Non-Executive Directors: Nitaben Bharatbhai Shah, Ajay R. Gandhi, Umesh P. Mehta, and Avni Chouhan. This diverse team oversees the company's governance and strategic direction.

As of March 2023, the management team of Hipolin includes the following individuals:<BR><BR>1. Shaileshkumar Jayantilal Shah - Chairman / Executive Director<BR>2. Daxesh B Shah - Executive Director<BR>3. Samir Rohit Shah - Executive Director<BR>4. Nitaben Bharatbhai Shah - Independent Non-Executive Director<BR>5. Ajay R. Gandhi - Independent Non-Executive Director<BR>6. Umesh P. Mehta - Independent Non-Executive Director<BR>7. Dimpal Sheth - Executive Director<BR>8. Avni Chouhan - Independent Non-Executive Director<BR>9. Avni Chouhan - Additional Independent Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

How big is Hipolin?

As of 23rd July, Hipolin Ltd has a market capitalization of 35.00 Cr and reported net sales of 21.57 Cr with a net loss of 3.26 Cr over the last four quarters. Shareholder's funds are 11.42 Cr, and total assets are valued at 16.28 Cr as of March 2024.

As of 23rd July, <BR><BR>Market Cap: Hipolin Ltd has a market capitalization of 35.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 21.57 Cr, while the sum of Net Profit for the same period reflects a loss of 3.26 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 11.42 Cr and Total Assets valued at 16.28 Cr.

How has been the historical performance of Hipolin?

Hipolin's historical performance shows increasing net sales from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, but rising expenditures have led to negative operating profits and a decline in profitability, with a profit before tax of -3.28 Cr in Mar'25. The company also faces challenges in cash flow, reporting -3.00 Cr from operating activities.

Answer:<BR>The historical performance of Hipolin shows a fluctuating trend in its financial metrics over the past four years.<BR><BR>Breakdown:<BR>Hipolin's net sales have increased from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, indicating a positive growth trajectory. However, total expenditure has also risen significantly, from 13.46 Cr in Mar'22 to 24.88 Cr in Mar'25, leading to a negative operating profit (PBDIT) of -3.32 Cr in Mar'25, compared to -1.24 Cr in Mar'22. The company reported a profit before tax of -3.28 Cr in Mar'25, down from a profit of 7.63 Cr in Mar'23, reflecting a substantial decline in profitability. The total assets decreased from 16.28 Cr in Mar'24 to 12.98 Cr in Mar'25, while total liabilities also fell from 16.28 Cr to 12.98 Cr in the same period. Cash flow from operating activities has remained negative, with -3.00 Cr reported in Mar'25, indicating ongoing challenges in generating cash from operations. Overall, while Hipolin has shown growth in sales, it faces significant challenges in managing costs and profitability.

When is the next results date for Hipolin Ltd?

The next results date for Hipolin Ltd is 14 February 2026.

The next results date for Hipolin Ltd is scheduled for 14 February 2026.

Are Hipolin Ltd latest results good or bad?

Hipolin Ltd's latest results are concerning, showing a breakeven net profit of ₹0.00 crores due to cost-cutting rather than operational improvement, alongside a 42.39% decline in revenue year-on-year. The company's negative return on equity of -40.05% raises serious concerns about its long-term viability.

Hipolin Ltd's latest results can be characterized as concerning rather than good. While the company reported a breakeven net profit of ₹0.00 crores for Q2 FY26, this result was primarily achieved through aggressive cost-cutting measures rather than any significant operational improvement. The operating profit margin remains at 0.0%, indicating a lack of profitability in core operations.<BR><BR>The revenue situation is particularly alarming, with net sales declining by 42.39% year-on-year to ₹3.18 crores, marking the sixth consecutive quarter of revenue decline. This trend suggests that the company is losing market share and facing serious challenges in a competitive FMCG landscape. Additionally, the return on equity (ROE) is deeply negative at -40.05%, highlighting significant capital destruction and raising concerns about the company's long-term viability.<BR><BR>Overall, while the technical breakeven might seem like a positive development, the underlying financial health of Hipolin Ltd is troubling, with ongoing revenue collapse and no clear path to recovery.

Should I buy, sell or hold Hipolin Ltd?

Which are the latest news on Hipolin?

Why is Hipolin Ltd falling/rising?

As of 31-Mar, Hipolin Ltd's stock price is Rs 46.79, reflecting a 4.99% decline. The stock has significantly underperformed the Sensex over various periods, with a year-to-date decrease of 19.23% and a 45.91% drop over the past year.

As of 31-Mar, Hipolin Ltd's stock price is falling, currently at Rs 46.79, which reflects a decrease of Rs 2.46 or 4.99%. This decline is evident in the stock's performance over various periods, including a 1-month drop of 14.35% compared to a 10.33% decline in the Sensex, and a year-to-date decrease of 19.23% against a 15.57% drop in the benchmark index. Over the past year, the stock has plummeted by 45.91%, significantly underperforming the Sensex, which only fell by 7.06%.<BR><BR>Today's trading activity indicates that the stock is close to its 52-week low, being just 4.19% away from Rs 44.83. Additionally, the stock has underperformed its sector by 3.5% today and has shown erratic trading patterns, not trading on one day out of the last 20. The stock reached an intraday low of Rs 46.79, and it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages.<BR><BR>Despite a rise in investor participation, with delivery volume increasing by 86.39% on March 25, the overall liquidity remains low, indicating challenges in trading activity. These factors collectively contribute to the stock's downward trajectory.